Hricik, D E <br/><br/>
Interferon Gamma ELISPOT Testing as a Risk-Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT-01 Multicenter Study.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Dec 2015 
 - 3166-73 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/ajt.13401  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Antilymphocyte Serum--immunology<br/>Biomarkers--analysis<br/>Child<br/>Enzyme-Linked Immunosorbent Assay--methods<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Graft Rejection--diagnosis<br/>Graft Survival<br/>Humans<br/>Interferon-gamma--analysis<br/>Kidney Failure, Chronic--surgery<br/>Kidney Function Tests<br/>Kidney Transplantation--adverse effects<br/>Male<br/>Middle Aged<br/>Postoperative Complications<br/>Prognosis<br/>Prospective Studies<br/>Rabbits<br/>Risk Factors<br/>Tissue Donors